Genotype, Viral Load and Age as Independent Predictors of Treatment Outcome of Interferon-α2a Treatment in Patients with Chronic Hepatitis C

References

• Hoofnagle J H, Mullen K D, Jones D B, Rustgi V, Di Bisceglie A, Peters M, Waggoner J G, Park Y, Jones E A. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha-interferon: A preliminary report. N Engl J Med 1986; 315: 1575–1578
   PubMed Web of Science ®Google Scholar
• Davis G L, Balart L A, Schiff E R, Lindsay K, Bodenheimer H C, Perrillo R P, Carey W, Jacobson I M, Payne J, Dienstag J L, van Thiel D H, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego T J, Gibas A. The Hepatitis I Nterventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501–1506
   PubMed Web of Science ®Google Scholar
• Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomized clinical trials. J Hepatology 1991; 13: 192–199
   PubMed Web of Science ®Google Scholar
• Reichard O, Foberg U, Fryden A, Mattson L, Norkrans G, Sønnerborg A, Wejstål R, Yun Z B, Weiland O. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha-2b for 60 weeks. Hepatology 1994; 19: 280–285
   PubMed Web of Science ®Google Scholar
• Lindsay K L, Davis G L, Schiff R, Bodenheimer H, Balart L, Dienstag J, Perrillo R, Tamburro C, Silva M, Goff C, Everson G, Sanghvi B, Albrecht J. Long-term response to higher doses of interferon (IFN) alpha-2b treatment of patients with chronic hepatitis C: A randomized multicenter trial. Hepatology 1993; 18: 106A
   Google Scholar
• Bjøro K, Krarup H, Bell H, Christoffersen P, Evensen S, Frøland S S, Laursen A, von der Lippe B, Mæland A, Ranek L, Ring-Larsen H, Schou G, Schrumpf E, Tygstrup N. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices. Scand J Gastroenterol 1995; 30: 1119–1124
   PubMed Web of Science ®Google Scholar
• Knodell R G, Ishak K G, Black W C, Chen T S, Craig R, Kaplowitz N, Kiernan T W, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–435
   PubMed Web of Science ®Google Scholar
• Young K KY, Resnick R M, Myers T W. Detection of hepatitis C virus RNA by a combined reverse transcription–polymerase chain reaction assay. J Clin Microbiol 1993; 31: 882–886
   PubMed Web of Science ®Google Scholar
• Bhattacherjee V, Prescott L E, Pike I, Rodgers B, Bell H, El-Zaiadi A R, Kew M C, Conradie J, Lin C K, Marsden H, Saed A A, Parker D, Yap P-L, Simmonds P. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 1995; 76: 1737–1748
   PubMedGoogle Scholar
• Fried M W, Hoofnagle J H. Therapy of hepatitis C. Sem Liv Dis 1995; 5: 82–91
   Google Scholar
• Ryff J-C. Usefulness of interferon treatment of hepatitis C. J Hepatology 22 Suppl 1995; 1: 101–109
   Google Scholar
• Brouwer J T, Nevens F, Kleter G EM, Elewaut A, Adler M, Brenard R, Chamuleau R AFM, Michielsen P, Pirotte J, Hautekeete M L, Arendt B, Fevery J, Schalm S W. Efficacy of interferon dose and factors predictive of sustained response in chronic hepatitis C: final results of a Benelux multicenter study in 350 patients. J Hepatology 23 Suppl 1995; 1: 85, (Abstract WP4/25)
   Google Scholar
• Saracco G, Rosina F, Abate M L, Chiandussi L, Gallo B, Cerutti E, Di Napoli A, Solinas A, Deplano A, Tocco A, Cossu P, Chien D, Kuo G, Polito A, Weiner A J, Houghton M, Verme G, Bonino F, Rizetto M. Long-term follow-up patients with chronic hepatitis C treated with different doses of interferon-α2b. Hepatology 1993; 18: 1300–1305
   PubMedGoogle Scholar
• Diodati G, Bonetti P, Noventa F, Casarin C, Rugge M, Scaccabarozzi S, Tagger A, Pollice L, Tremolada F, Davite C, Realdi G, Ruol A. Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial. Hepatology 1994; 19: 1–5
   PubMed Web of Science ®Google Scholar
• Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen J L, Sajus M, Costa J M, Vinaud M, Chaput J C, The Multicenter Study Group. A comparison of three interferon alpha-2b regimens for the long term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332: 1457–1462
   PubMed Web of Science ®Google Scholar
• Tisminetzky S G, Gerotto M, Pontisso P, Chemello L, Ruvelotto M G, Barelle F, Alberti A. Genotypes of hepatitis C virus in Italian patients with chronic hepatitis C. Int Hepatol Commun 1994; 2: 105–112
   Google Scholar
• Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatology 1992; 14: 35–40
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itol Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–299
   PubMed Web of Science ®Google Scholar
• Hino H K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299–305
   PubMed Web of Science ®Google Scholar
• Tsubota A, Chayama K, Arase Y, Koida I, Saitoh S, Ikeda K, Iwasaki S, Matsumoto T, Kobayashi M, Kumuda H. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol 1993; 8: 535–539
   PubMed Web of Science ®Google Scholar
• Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088–1094
   PubMed Web of Science ®Google Scholar
• Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S. Quantification and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-b˜. Hepatology 1993; 18: 1319–1325
   PubMedGoogle Scholar
• Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap P-L, Sherlock S, McIntyre N, Simmonds P. Hepatitic C virus genotypes: An investigtion of type specific differences in geographic origin and disease. Hepatology 1994; 19: 13–18
   PubMed Web of Science ®Google Scholar
• Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, Frezza M, Noventa F, Pontisso P, Benvegnu L, Casarin C, Alberti A, TriVeneto Viral Hepatitis group. Randomized trial comparing three different regimens of alpha-2a interferon in chronic hepatitis type C. Hepatology 1995; 22: 700–706, andthe
   PubMed Web of Science ®Google Scholar
• Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizava H, Okamoto H. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV RNA. Dig Dis Sci 1994; 39: 441–444
   PubMed Web of Science ®Google Scholar
• Chayama K, Arase Y, Koida I, Tsubota A, Saitoh S, Ikeda K, Matsumoto T, Kanda M, Iwasaki S, Kobayashi M. Antiviral effect of lymphoblastoid interferon-alpha on hepatitis C virus in patients with chronic hepatitis C. J Gastroenterol Hepatol 1994; 9: 128–133
   PubMedGoogle Scholar
• Brechot C. Hepatitis C virus genetic variability: Clinical implications. Am J Gastroenterol 1994; 89: S41–S47
   PubMed Web of Science ®Google Scholar
• Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masuzawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T. Ability of prolonged Interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C. A multicenter randomized controlled trial. Hepatology 1995; 21: 291–297
   PubMed Web of Science ®Google Scholar
• Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570–583
   PubMed Web of Science ®Google Scholar
• Lau J YN, Davis G L, Kniffen J, Qian K P, Urdea M S, Chan C S, Mizokami M, Neuwald P D, Wilber J C. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501–1504
   PubMed Web of Science ®Google Scholar
• Nousbaum J-B, Stanislas P, Nalpas B, Landais P, Berthelot P, Brechot C, The Collaborative Study Group. Hepatitis C virus type 1b (II). Infection in France and Italy. Ann Int Med 1995; 122: 161–168
   PubMed Web of Science ®Google Scholar
• Smith D B, Davidson F, Yap P-E, Brown H, Kolberg J, Detmer J, Urdea M, Simmonds P, The International H CV, Collaborative Study Group. Levels of hepatitis C virus in blood donors infected with different viral genotypes. J Infect Dis 1996; 173: 727–730
   PubMedGoogle Scholar
• Pissinino F, Felaco F M, Aprea L, Messina V, Pasquale G, Sagnelli E. Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus. Arch Virol Suppl 1993; 8: 257–263
   PubMedGoogle Scholar
• Uchida T, Taira M, Shigata T, Moriyama M, Tanaka N, Okubo H, Arakawa Y. Histological differences between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol Jpn 1993; 43: 230–236
   PubMedGoogle Scholar
• Perez R, Pravia R, Linares A, Rodriguez M, Lombrana J LS, Suarez A, Riestra S, Navascues C A, Rodrigo L. Response related factors in recombinant interferon alpha-2b treatment of chronic hepatitis C. Gut Suppl 1994; 34: S139–S140
   Google Scholar
• Camps J, Chrisostomo S, Garcia-Granero M, Riezu-Boi J I, Civeira M P, Prieto J. Prediction of the response of chronic hepatitis C to interferon-alpha: a statistical analysis of pre-treatment variables. Gut 1993; 34: 1714–1717
   PubMed Web of Science ®Google Scholar